Literature DB >> 8962688

Effects of neonatal clomipramine on cholinergic receptor sensitivity and passive avoidance behavior in adult rats.

J Prathiba1, K B Kumar, K S Karanth.   

Abstract

The effects of neonatal treatment with clomipramine on the sensitivity of cholinergic receptor and passive avoidance behavior were studied to examine the activity of the central cholinergic system. Rat pups were treated twice daily from postnatal day 5 to 21 with clomipramine (15 mg/kg, s.c.) and at 3 months of age the thermic responses to three different doses of oxotremorine were measured. One day following oxotremorine challenge study, the animals were subjected to passive avoidance training and retention was measured 24-hr later. Clomipramine treated animals showed an enhanced cholinomimetic-induced hypothermia and an increased latency in passive avoidance test. These findings may reflect an altered sensitivity of central cholinergic system in rats given clomipramine as neonates. The results were compared to other animal models of depression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8962688     DOI: 10.1007/bf01271532

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  18 in total

Review 1.  Role of serotonin and other neurotransmitter receptors in brain development: basis for developmental pharmacology.

Authors:  P M Whitaker-Azmitia
Journal:  Pharmacol Rev       Date:  1991-12       Impact factor: 25.468

2.  Procedure- and age-dependent hyperactivity in a new animal model of endogenous depression.

Authors:  P Hartley; D Neill; M Hagler; D Kors; G Vogel
Journal:  Neurosci Biobehav Rev       Date:  1990       Impact factor: 8.989

3.  Stress induces supersensitivity of a cholinergic system in rats.

Authors:  S C Dilsaver; R M Snider; N E Alessi
Journal:  Biol Psychiatry       Date:  1986-09       Impact factor: 13.382

4.  Acetylcholine and the regulation of REM sleep: basic mechanisms and clinical implications for affective illness and narcolepsy.

Authors:  P J Shiromani; J C Gillin; S J Henriksen
Journal:  Annu Rev Pharmacol Toxicol       Date:  1987       Impact factor: 13.820

5.  Chronic stress and memory: implication of the central cholinergic system.

Authors:  R Zerbib; H Laborit
Journal:  Pharmacol Biochem Behav       Date:  1990-08       Impact factor: 3.533

Review 6.  A new animal model of endogenous depression: a summary of present findings.

Authors:  G Vogel; D Neill; M Hagler; D Kors
Journal:  Neurosci Biobehav Rev       Date:  1990       Impact factor: 8.989

7.  A possible mechanism for diisopropylfluorophosphate-induced memory loss in rats.

Authors:  R Gardner; R Ray; J Frankenheim; K Wallace; M Loss; R Robichaud
Journal:  Pharmacol Biochem Behav       Date:  1984-07       Impact factor: 3.533

8.  Suppression of active sleep by chronic treatment with chlorimipramine during early postnatal development: effects upon adult sleep and behavior in the rat.

Authors:  M Mirmiran; N E van de Poll; M A Corner; H G van Oyen; H L Bour
Journal:  Brain Res       Date:  1981-01-05       Impact factor: 3.252

9.  Amitriptyline supersensitizes a central cholinergic mechanism.

Authors:  S C Dilsaver; R M Snider; N E Alessi
Journal:  Biol Psychiatry       Date:  1987-04       Impact factor: 13.382

10.  Increased REM sleep in rats selectively bred for cholinergic hyperactivity.

Authors:  P J Shiromani; D Overstreet; D Levy; C A Goodrich; S S Campbell; J C Gillin
Journal:  Neuropsychopharmacology       Date:  1988-05       Impact factor: 7.853

View more
  2 in total

1.  Effects of adolescent fluoxetine treatment on fear-, anxiety- or stress-related behaviors in C57BL/6J or BALB/cJ mice.

Authors:  Maxine Norcross; Poonam Mathur; Mathur Poonam; Abigail J Enoch; Rose-Marie Karlsson; Jonathan L Brigman; Heather A Cameron; Judith Harvey-White; Andrew Holmes
Journal:  Psychopharmacology (Berl)       Date:  2008-07-02       Impact factor: 4.530

2.  Chronic escitalopram treatment restores spatial learning, monoamine levels, and hippocampal long-term potentiation in an animal model of depression.

Authors:  V Bhagya; B N Srikumar; T R Raju; B S Shankaranarayana Rao
Journal:  Psychopharmacology (Berl)       Date:  2010-11-04       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.